Meridian Medical Technologies is a global leader in the medical device industry, serving the emergency and early intervention healthcare markets. Meridian is comprised of two business units: Cardiopulmonary Diagnostics and Specialty Pharmaceuticals. Meridian's newest product in Cardiopulmonary Diagnostics is the Prime ECG™ electrocardiac mapping system, a non-invasive device designed to detect a heart attack earlier and more effectively than current technology. Meridian's Specialty Pharmaceuticals' manufactures the life-saving EpiPen® auto-injector, is the sole supplier of auto-injectors for nerve agent antidotes to the U.S. government and other NATO allies, states and local municipalities, and manages a large commercial drug delivery business.